Phase 2Recruiting

Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty

A Multicenter, Randomized, Open-label, Positive-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of H001 Capsules in the Prevention of Venous Thromboembolism (VTE) in Subjects Undergoing Total Knee Arthroplasty

Sponsor
Livzon Pharmaceutical Group Inc. (Industry)
Enrollment
320 planned
Conditions
Circulatory Disease
Interventions
H001 Capsule 200mg-qd; Enoxaparin Sodium Injection; H001 Capsule 300mg-qd; H001 Capsule 200mg-bid
Ages
adults, older adults
Registry
NCT06963320

Full record on ClinicalTrials.gov

From the registry

This study is a multicenter, randomized, open-label, positive-controlled Phase II clinical study to evaluate the efficacy and safety of H001 capsules in the prevention of venous thromboembolism (VTE) in subjects undergoing Total Knee Arthroplasty.

Primary outcomes

  • Incidence of total VTE

History

  1. Study completion

  2. Primary completion

  3. Registered

  4. Started